PHP
AXNX

Parkman Healthcare Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Parkman Healthcare Partners’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-176,950
Closed -$9.03M – 97
2020
Q3 		$9.03M Sell
176,950
-64,959
-27% -$2.71M 2.39% 11
2020
Q2 		$8.49M Hold
241,909
– – 2.39% 9
2020
Q1 		$6.15M Buy
241,909
+75,678
+46% +$2.25M 2.85% 9
2019
Q4 		$4.61M Buy
+166,231
New +$3.97M 1.33% 29

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Parkman Healthcare Partners's AXNX Position: Q4 2020 in Review

Parkman Healthcare Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2020, closing a stake of 176,950 shares — an estimated $9.03M sold.

Parkman Healthcare Partners first reported a position in AXNX in Q4 2019 and held it in 4 quarters. The position peaked at $9.03M in Q3 2020. 149 funds tracked by Wall St. Rank hold AXNX as of Q4 2020.

  • Parkman Healthcare Partners reported no remaining Axonics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Parkman Healthcare Partners sold 176,950 Axonics, Inc. Common Stock shares in Q4 2020, an estimated $9.03M.
  • Parkman Healthcare Partners first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Parkman Healthcare Partners's Axonics, Inc. Common Stock position peaked at $9.03M in Q3 2020.
  • 149 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2020.

Based on Parkman Healthcare Partners's 13F filing for Q4 2020, filed 12 Feb 2021.